Visit https://www.peervoice.com/VXE860 to view the entire programme with slides. After completing “Can Long-Acting Injectables Make a Difference in HIV?”, participants will be able to: Evaluate the clinical evidence for long-acting injectable therapy for people living with HIV (PLWH); Summarise the potential benefits and limitations of daily vs long-acting therapy in the long-term management of HIV; Create individualised management strategies for therapy for PLWH, taking into account patient needs.